跳至主要内容
临床试验/NCT04460131
NCT04460131招募中不适用

Association Between Soluble ST2 and Cardiovascular Outcome After Cardiovascular Surgery

Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
All-cause mortality

研究概览

简要总结

Cardiac surgery induces hemodynamic stress on the myocardium, and this process can be associated with significant cardiovascular morbidity and mortality. Soluble suppression of tumorigenicity 2 (sST2) is biomarker of myocardial remodeling and fibrosis; however, little is known regarding their potential association with cardiovascular events. This study aimed to investigate the release of sST2 and its association with cardiovascular events undergoing cardiac surgery.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age ≥ 18 years
  • Congenital heart disease requiring surgery
  • Valvular heart disease requiring surgery
  • Arrhythmia requiring surgery
  • Aortic dissection requiring surgery
  • Coronary heart disease requiring surgery

排除标准

  • age <18 years
  • pregnancy
  • severe renal dysfunction (creatinine >200µmol/L)
  • not capable of understanding or signing informed consent.

结局指标

主要结局

All-cause mortality

时间窗: 30 days after surgery

Number of participants death of 30 days after surgery

次要结局

  • Heart failure(30 days after surgery)

研究者

发起方
Nanjing Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hong Liu

Investigator of Nanjing Medical University

Nanjing Medical University

研究点 (1)

Loading locations...

相似试验